Interest Expense On Debt Endring Dato
AbbVie USD 555M 3M 2023-09
Alnylam Pharmaceuticals USD 31.34M 445K 2023-12
Amgen USD 821M 62M 2023-12
Biogen USD 71.5M 7.7M 2023-12
BioMarin Pharmaceutical USD 6.1M 2.32M 2023-12
Bristol-Myers Squibb USD 316M 36M 2023-12
Eli Lilly USD 124.6M 4.3M 2023-09
Esperion Therapeutics USD 15M 458K 2023-09
Gilead Sciences USD 252M 20M 2023-12
Incyte USD 804K 181K 2023-12
Ionis Pharmaceuticals USD 4.56M 355K 2023-12
J&J USD 192M 154M 2023-09
Merck USD 317M 40M 2023-09
Moderna USD 6M 4M 2023-12
Neurocrine Biosciences USD 1.1M 200K 2023-09
Opthea USD 9.98M 6.5M 2023-06
Pfizer USD 689M 6M 2023-12
Regeneron Pharmaceuticals USD 18.3M 500K 2023-12
Roche Holding CHF 401M 53M 2023-06
Sarepta Therapeutics USD 5.23M 5K 2023-09
Teva Pharmaceutical Industries USD 247M 31M 2023-09
United Therapeutics USD 15.1M 500K 2023-12
Vertex Pharmaceuticals USD 10.9M 300K 2023-09



Regeneron Pharmaceuticals Rentekostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2024.